Events & Presentations

Featured Event

Date	Event Details	Remind Me
Summary Toggle Dec 3, 2020 11:00 AM EST	Annual Meeting of Stockholders Click here for webcast Transcript of December 3, 2020, GALT Annual Meeting 316.2 KB

Presentations

Date	Title
Dec 03, 2020	Add Files Transcript of December 3, 2020, GALT Annual Meeting 316.2 KB
Sep 29, 2020	Add Files Corporate Update Presentation 1 MB
Sep 14, 2020	Add Files Corporate Update Presentation 1.1 MB
Dec 04, 2019	Add Files Corporate Update Presentation 1 MB
Nov 20, 2019	Add Files Galectin Therapeutics - Corporate Overview March 2019 2.1 MB
Nov 20, 2019	Add Files AFDD Presentation November 2019 2.8 MB
Jul 15, 2019	Add Files GR-MD-02: Phase III Galectin-3 Inhibitor 2.4 MB
Apr 08, 2019	Add Files 2019 H.C. Wainwright Global Life Sciences Presentation 1.7 MB
Sep 06, 2018	Add Files H.C. Wainwright 20th Annual Global Investment Conference Presentation 1.5 MB
Jul 16, 2018	Add Files Corporate Presentation 2.4 MB
Apr 16, 2018	Add Files Galectin Therapeutics Late-Breaker Presentation at The International Liver Congress Reinforces and Extends the Positive Effects of GR-MD-02 in Patients With NASH Cirrhosis 1.1 MB
Mar 12, 2018	Add Files 30th Annual ROTH Conference Presentation 2.2 MB
Feb 06, 2018	Add Files GR-MD-02 for Indication of NASH Cirrhosis: NASH-CX Clinical Trial Results (Supplemental Information to Corporate Presentation) 1 MB
Feb 06, 2018	Add Files The Galectin-3 Inhibitor GR-MD-02 for Combination Cancer Immunotherapy (Supplemental Information to Corporate Presentation) 930.3 KB
Jan 08, 2018	Add Files J.P. Morgan Healthcare Conference Presentation 1.1 MB
Dec 14, 2017	Add Files Galectin Therapeutics 2017 Annual Meeting of Shareholders - Corporate Update Presentation 435.1 KB
Dec 05, 2017	Add Links to Pages NASH Infographic
Dec 05, 2017	Add Files Galectin Therapeutics Phase 2b NASH-CX Trial Results Presentation 6.5 MB
Nov 11, 2017	Add Files Annual Meeting of the Society for Cancer Immunotherapy Poster Presentation (GR-MD-02 plus Anti-PD-1) 3 MB
Nov 11, 2017	Add Files Annual Meeting of the Society for Cancer Immunotherapy Poster Presentation (GR-MD-02 plus aOX40) 6.4 MB
Sep 13, 2017	Add Files Galectin Therapeutics Corporate Presentation 2.8 MB
Apr 20, 2017	Add Files The International Liver Congress 2017: Late-Breaking Abstract Poster Presentation 795.3 KB
Feb 07, 2017	Add Files Immunotherapeutics & Immunomonitoring Conference Presentation 2.7 MB

Archived Events

Date	Event Details
Summary Toggle Sep 29, 2020 4:00 PM EDT	Galectin Therapeutics Investor Update Call Click here for webcast Corporate Update Presentation 1 MB
Summary Toggle Sep 14, 2020 12:30 PM EDT	H.C. Wainwright 22nd Annual Global Investment Conference Click here for webcast
Summary Toggle Feb 11, 2020 3:00 PM GMT	3rd Global NASH Congress 2020 Location London Heathrow Marriott Speaker Harold H. Shlevin, Ph.D. Consultant, Director and former Chief Executive Officer
Summary Toggle Dec 4, 2019 9:30 AM EST	Corporate Update Listen to Replay of the Webcast 49 MB Corporate Update Presentation 1 MB Transcript of the Q&A Following the 12/4 Corporate Update Presentation 125.9 KB
Summary Toggle Apr 9, 2019 5:30 AM EDT	2019 H.C. Wainwright Global Life Sciences Conference Listen to webcast View Presentation 1.7 MB
Summary Toggle Sep 6, 2018 9:35 AM EDT	H.C. Wainwright 20th Annual Global Investment Conference Listen to webcast H.C. Wainwright 20th Annual Global Investment Conference Presentation 1.5 MB
Summary Toggle Apr 14, 2018 4:00 PM CEST	The International Liver CongressTM 2018, European Association for the Study of the Liver (EASL) Galectin Therapeutics to Present Late-Breaker Oral Presentation at The International Liver Congress 2018
Summary Toggle Apr 9, 2018 7:45 AM EDT	H.C. Wainwright Global Life Sciences Conference Listen to webcast
Summary Toggle Mar 19, 2018 4:00 PM EDT	2nd Annual H.C. Wainwright NASH Investor Conference. New York, NY Listen to webcast Presentation 1.6 MB
Summary Toggle Mar 19, 2018 4:00 PM JST	Bio Asia, Tokyo, Japan
Summary Toggle Mar 17, 2018 8:30 AM HKT	CHIPS, Hangzhou, China Listen to webcast
Summary Toggle Mar 12, 2018 2:00 PM PDT	30th Annual ROTH Conference Listen to webcast 30th Annual ROTH Conference Presentation 2.2 MB
Summary Toggle Feb 13, 2018 10:15 AM EST	Galectin Therapeutics at BIO CEO & Investor Conference Location New York Marriott Marquis , New York City Click here for webcast Corporate Presentation 2.4 MB GR-MD-02 for Indication of NASH Cirrhosis: NASH-CX Clinical Trial Results (Supplemental Information to Corporate Presentation) 1 MB
Summary Toggle Dec 14, 2017 9:00 AM EST	Galectin Therapeutics 2017 Annual Meeting of Shareholders - Corporate Update Listen to webcast Galectin Therapeutics 2017 Annual Meeting of Shareholders - Corporate Update Presentation 435.1 KB View Additional Information Webcast to begin at approximately 9 a.m. ET on Thursday, December 14, 2017 The webcast may be accessed directly via the following link: https://dentons.adobeconnect.com/galt_board/ Type your full name in the blank field to "Enter as a Guest" and click the "Enter Room" button. The presentation may also be heard via teleconference by dialing 866.225.1342 (within the United States). A list of international dial-in numbers can be found here. The passcode for participants is 2856445641. Please dial-in or log-in approximately 10 minutes before the event begins to ensure a timely connection.
Summary Toggle Dec 5, 2017 8:30 AM EST	Galectin Therapeutics Phase 2b NASH-CX Trial Results Presentation Listen to webcast View Additional Information Live Dial-in: 888-317-6003 Pin #: 3493752 Replay Dial-in: 877-344-7529 Pin #: 10114808
Summary Toggle Sep 12, 2017 11:40 AM EDT	Galectin Therapeutics to Present at the Rodman & Renshaw 19th Annual Global Investment Conference Listen to webcast
Summary Toggle Jul 13, 2017 3:30 PM EDT	Singular Research Summer Conference Listen to webcast
Summary Toggle Mar 15, 2017 11:30 AM PDT	29th Annual ROTH Conference Listen to webcast Presentation 2.1 MB
Summary Toggle Feb 13, 2017 3:00 PM EST	BIO CEO & Investor Conference Webcast Presentation Listen to webcast Presentation 2.2 MB
Summary Toggle Feb 2, 2017 11:30 AM EST	VirtualInvestorConferences.com Listen to webcast Presentation 1.6 MB
Summary Toggle Dec 15, 2016 1:30 PM EST	Galectin Therapeutics 2016 Annual Meeting of Stockholders - Corporate Update Webcast 2016 Annual Stockholder Meeting Presentation Slides 2.8 MB 2016 Annual Stockholder Meeting Transcript 1.9 MB View Additional Information Galectin Therapeutics 2016 Annual Meeting of Stockholders - Corporate Update Webcast to begin at approximately 1:30 p.m. ET on Thursday, December 15, 2016 The webcast may be accessed directly via the following link: https://dentons.adobeconnect.com/galt_board/ The presentation may also be heard via teleconference by dialing 866-225-1342 (within the United States). A list of international dial-in numbers can be found here: https://www.tcconline.com/listNumbersByCode.action?confCode=8620018752 The passcode for participants is 8620018752 Please log in approximately 10 minutes before the event to ensure a timely connection.
Summary Toggle Sep 27, 2016 5:30 PM EDT	Business Update Conference Call & Webcast Transcript 94 KB View Additional Information Participant dial-in number: 1-888-317-6003 Pin number: 4681161 Webcast link: http://services.choruscall.com/links/galt160927.html
Summary Toggle Sep 12, 2016 3:50 PM EDT	Rodman & Renshaw 18th Annual Global Investment Conference Listen to webcast
Summary Toggle May 21, 2015 12:00 AM EDT	2015 Annual Stockholder Meeting Listen to webcast View Additional Information Galectin Therapeutics (Nasdaq:GALT) hosted a corporate update webcast on Thursday, May 21, 2015, immediately following the business portion of the Company’s Annual Meeting of Stockholders. Peter Traber, M.D., president, chief executive officer and chief medical officer discussed the company’s pipeline of galectin inhibitor compounds and progress in development of treatments for liver fibrosis and cancer. View the video replay: http://galectintherapeutics.com/stockholder-meeting-webcast/
Summary Toggle May 14, 2014 10:00 AM EDT	2014 Annual Stockholder Meeting 2014 Annual Stockholder Meeting Presentation 1.8 MB View Additional Information Galectin Therapeutics (NASDAQ: GALT) held a webcast to provide an update following the Company's Annual Meeting of Shareholders. To view a PDF of the document referenced in the webcast, click here.

Events & Presentations

Featured Event

Annual Meeting of Stockholders

Upcoming Events

Presentations

Archived Events

Galectin Therapeutics Investor Update Call

H.C. Wainwright 22nd Annual Global Investment Conference

3rd Global NASH Congress 2020

Location

Speaker

Corporate Update

2019 H.C. Wainwright Global Life Sciences Conference

H.C. Wainwright 20th Annual Global Investment Conference

The International Liver CongressTM 2018, European Association for the Study of the Liver (EASL)

H.C. Wainwright Global Life Sciences Conference

2nd Annual H.C. Wainwright NASH Investor Conference. New York, NY

Bio Asia, Tokyo, Japan

CHIPS, Hangzhou, China

30th Annual ROTH Conference

Galectin Therapeutics at BIO CEO & Investor Conference

Location

Galectin Therapeutics 2017 Annual Meeting of Shareholders - Corporate Update

Galectin Therapeutics Phase 2b NASH-CX Trial Results Presentation

Galectin Therapeutics to Present at the Rodman & Renshaw 19th Annual Global Investment Conference

Singular Research Summer Conference

29th Annual ROTH Conference

BIO CEO & Investor Conference Webcast Presentation

VirtualInvestorConferences.com

Galectin Therapeutics 2016 Annual Meeting of Stockholders - Corporate Update Webcast

Business Update Conference Call & Webcast

Rodman & Renshaw 18th Annual Global Investment Conference

2015 Annual Stockholder Meeting

2014 Annual Stockholder Meeting